Post-approval studies (Phase 4)Not Yet RecruitingNCT06788340
What this trial is testing
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Odense University Hospital 166